Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3794-3797

  Rood, Brian R ^a   Zhang, Huizhen ^a   Weitman, David M ^a   Cogen, Philip H ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN HIC 1; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; GENE DELETION; GENE INACTIVATION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; METHYLATION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; CPG ISLANDS; DNA METHYLATION; HUMANS; LOSS OF HETEROZYGOSITY; MEDULLOBLASTOMA; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 0036644901     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis
2. Tumor suppressor genes and medulloblastoma
3. Prognostic significance of molecular genetic markers in childhood brain tumors
4. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system
5. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors
6. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53
7. Deletion mapping on chromosome 17p in medulloblastoma
8. HIC1 hypermethylation is a late event in hematopoietic neoplasms
9. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system
10. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma
11. Mitotic percentage index: A new prognostic factor for childhood medulloblastomal
12. Prognostic factors in adult medulloblastoma. A clinico-pathologic study
13. Potential prognostic value of C-erbB-2 expression in medulloblastomas in very young children
14. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
15. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma
16. Prognostic implications of chromosome 17p deletions in human medulloblastomas
17. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma
18. p53 activates expression of Hic-1, a new candidate tumour suppressor gene on 17p13.3
19. Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia
20. Mutation and cancer: Statistical study of retinoblastoma
21. DNA methylation
22. Alterations in DNA methylation may play a variety of roles in carcinogenesis
23. Cancer epigenetics comes of age
24. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis
25. DNA methylation affects the formation of active chromatin
26. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma
27. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors
28. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
29. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
30. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
31. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma
32. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
33. Gene silencing. Methylation meets acetylation
34. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
35. Wolffe MeCP2 recruit histone deacetylase to repress transcription
36. Histone acetylation in chromatin structure and transcription
37. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
38. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer
39. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance
40. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcino-genesis
41. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors
42. DNA hypermethylation is associated with 17p allelic loss in neural tumors
43. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history
44. DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis
45. Delayed replication of Xq27 in individuals with the fragile X syndrome